| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000039017 |
| Receipt No. | R000044475 |
| Scientific Title | Effect of hip range of motion on batting movement |
| Date of disclosure of the study information | 2019/12/27 |
| Last modified on | 2021/03/24 (Ver. 5) |
| Basic information | ||
| Public title | Effect of hip range of motion on batting movement | |
| Acronym | Effect of hip range of motion on batting movement | |
| Scientific Title | Effect of hip range of motion on batting movement | |
| Scientific Title:Acronym | Effect of hip range of motion on batting movement | |
| Region |
|
|
| Condition | |||
| Condition | A healthy adult male who is currently playing baseball at least three days a week.More 5 years of experience. | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Analyzing the effect of hip mobility on trunk movement during a follow-swing will help prevent disorders due to swing motion and assist in conditioning guidance.
|
| Basic objectives2 | Others |
| Basic objectives -Others | It is thought that a decrease in the range of motion of the hip joint may increase trunk extension, rotation, and lateral bending during follow-swing, and increase the load on the lumbar spine.Studies that actually compared physical function and swing motion are limited. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Measure the range of motion of the trunk flexion and extension, lateral bending, rotation, hip joint flexion and extension, adduction and abduction, and internal rotation and external rotation during the follow swing.
Vicon Nexus2(Inter Reha co., ltd) and 10 cameras are used for the measurement. The camera frequency is set to 250Hz based on previous research. |
| Key secondary outcomes | Measure the range of motion of trunk flexion and extension, lateral bending, rotation, hip flexion and extension, adduction and abduction, and internal rotation and external rotation according to the methods established by the Japanese orthopaedic association and the Japanese association of rehabilitation medicine. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | After measuring the range of motion , warm up in 10 minutes, including stretching and swinging.
After that, practice tee batting about 10 times. After practice, place markers on the sternum, C7, xiphoid process, T7, right and left ASIS, PSIS midpoint, left and right greater trochanter, left and right femoral medial epicondyle, left and right femoral lateral epicondyle, bat head, ball Attach it. Hit the sponge ball with a tee batting. Hit the ball in the direction of the center. Dry swing and hits in obviously different directions will be considered failures. The measurement continues until three successful attempts. The measurement is carried out in one day and takes about 50 minutes. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 20 years or older.
Play baseball more than 3 days a week. More than 5 years of experience. |
|||
| Key exclusion criteria | Exclude those that do not meet the above.
Those who have pain somewhere and have difficulty swinging at full power are also excluded. Participants were not consent. |
|||
| Target sample size | 20 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Gunma University | ||||||
| Division name | Graduate school of Health Sciences | ||||||
| Zip code | 371-8511 | ||||||
| Address | 3-39-22 Showamachi,Maebashi,Gunma | ||||||
| TEL | 027-220-8972 | ||||||
| msaka@gunma-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gunma University | ||||||
| Division name | Graduate school of Health Sciences | ||||||
| Zip code | 371-8511 | ||||||
| Address | 3-39-22 Showamachi,Maebashi,Gunma | ||||||
| TEL | 090-5231-4826 | ||||||
| Homepage URL | |||||||
| h181c015@gunma-u.ac.jp | |||||||
| Sponsor | |
| Institute | Graduate school of Health Sciences,Gunma University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Human Medical Research Ethics Review Committee |
| Address | 3-39-15 Showamachi, Maebashi City ,Gunma |
| Tel | 027-220-8740 |
| hitotaisho-ciru@ml.gunma-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 15 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000044475 |